Heart health after cancer

Published Catarina de Freitas on

Monday Lunch Live

24 August 2026 (Video recording below) 

Cardio-oncology: Cancer and heart health and the SOCRATES study

Heart disease is common during and after cancer treatment. This is due to common shared risk factors between both conditions, similarities in underlying disease pathophysiology, and cardiotoxic effects of several cancer treatments. In this talk, Dr Sean Tan discusses the new and growing field of Cardio-Oncology as well as active research studies investigating the intersection between cancer and heart disease.

Chair 

Pauline Ryan
Program Manager, Statewide Cancer Consumer-led Research Partnership, VCCC Alliance

 

Speakers

Dr Sean Tan
Cardiologist and Research Fellow, Victorian Heart Hospital (Monash Health) and Victorian Heart Institute (Monash University)

Dr Sean Tan is an academic cardio-oncologist and researcher based at the Victorian Heart Hospital and Monash University. A cardiologist by training, he recently completed a PhD evaluating cardiovascular risk in people with cancer treated with immunotherapy.

He is currently the lead investigator in several Australian multicentre cardio-oncology trials, including the SOCRATES and MONITOR-HER2 studies. Dr Tan is also an avid educator and the Clinical Dean for Monash University medical students placed at the Victorian Heart Hospital.

Peter Doyle
Lived Experience Representative

Peter is a retired Firefighter and diagnosed with Melanoma in May 2021. Initial surgery was excision and pathology with further surgery Encompassing wide local excision of the Right Neck. Determined at that stage to be stage 1b. In late 2023 the cancer returned as a Lump in the neck lymph node and further surgery was performed in February 2024. Prior to the surgery, immunotherapy was started (3 weeks) and then continued following for 12 months. The cancer returned, again in the lymph nodes, and a level 5 neck direction was completed in Nov 2024 (this was during immunotherapy). Further monitoring and Scans (MRI, PET) were carried out 3 monthly, with a scan in Nov 2025 detecting an anomaly in the Heart arteries (stenosis). Peter was then referred to Dr Sean Tan and the Socrates trial with further treatment at the VHH in Nov 2025 and Jan 2026. To date the scans at Peter Mac are continuing as is involvement in the Socrates trial.

Resource details

two_hands_one_heart
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Prevention, screening and diagnostics
Research (incl. Clinical Trials)
Clinical Care
Speciality
Clinician
Consumer / patient / carer
Early to mid career researcher
Nurse
Senior researcher / scientist
Clinical care
Monday Lunch Live
Research

This course is brought to you by

Alliance members